Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual

Nov 03, 2021 8:45 AM - Nov 05, 2021 1:15 PM

(Central Europe Standard Time)

Global Forum for Qualified Persons for Pharmacovigilance (QPPV)

15th Anniversary

Session 3: QPPV Requirements And Expectations In Non-Eu Countries

Session Chair(s)

Shahinaz  Badr, PHARMD

Shahinaz Badr, PHARMD

Founder & Managing Director, Vigilance Gate FZ,LLC, United Arab Emirates

Willemijn  van der Spuij, MSC

Willemijn van der Spuij, MSC

Executive Director Europe | International - Patient Safety, Bristol Myers Squibb, Switzerland

Over the years global development of QPPV requirements have been implemented. We will address multiple regions and countries to identify the different local requirements implemented and how does this affect the PV system. Differences and similarities of the requirements and responsibilities for non-EU QPPV and EU QPPV will be explored including high level consideration of:

  • how this will influence or impact the EU QPPV
  • Opportunities and Challenges in the oversight

Leading to session 4: You by now well informed on the requirements so let us explore how can we implement those requirements in the PV system through session 4.

Speaker(s)

Willemijn  van der Spuij, MSC

Willemijn van der Spuij, MSC

Executive Director Europe | International - Patient Safety, Bristol Myers Squibb, Switzerland

Presentation covering Europe (Turkey, Serbia, Switzerland)

Moonjung  Kim, RPH

Moonjung Kim, RPH

Director, Korea Institute of Drug Safety and Risk Management, Korea, Republic of

Roles and Responsibilities of Safety Control Manager in Korea

Heather  Yoo, MPHARM, RPH

Heather Yoo, MPHARM, RPH

Head of Patient Safety, South East Asia, Bristol-Myers Squibb, Singapore

Overview of Local QPPV requirements in Asia Pacific

Sophie  Fontez

Sophie Fontez

Director, Global Clinical Safety and Pharmacovigilance (GCSP) Regions Lead (Asia, -Pacific), CSL Behring, Australia

Overview of Local QPPV requirements in Asia Pacific

Nadjat  LOUMI-MEDEDJEL

Nadjat LOUMI-MEDEDJEL

Responsible for Training of Healthcare Professionals and Staff, Centre National De Pharmacovigilance et De Matériovigilance (CNPM), Algeria

Middle East and North Africa: Regulators Introduction from Algeria, Iraq, Kuwait

Manal  Younus

Manal Younus

Head of Iraqi Pharmacovigilance Centre, Directorate of Technical Affairs, Ministry of Health, Iraq

Middle East and North Africa: Regulators Introduction from Algeria, Iraq, Kuwait

Reem   El Essa

Reem El Essa

Senior Pharmacy Specialist and Inspector Pharmacist at Drug Inspection, Administration, Pharmacovigilance Focal Point in Kuwait Drug and Food Control, Kuwait

Middle East and North Africa: Regulators Introduction from Algeria, Iraq, Kuwait

Shahinaz  Badr, PHARMD

Shahinaz Badr, PHARMD

Founder & Managing Director, Vigilance Gate FZ,LLC, United Arab Emirates

Updates from MENA Region

Ana Paula  Goncalves

Ana Paula Goncalves

Senior Director, Patient Safety Intercontinental, Bristol-Myers Squibb , Brazil

Discussion covering Latin America (Brazil)

Olga  Ermishina, MD

Olga Ermishina, MD

Pharmacovigilance Country Head, Qualified Person for Pharmacovigilance in EAEU, Bayer, Russian Federation

Presentation covering Eurasia

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.